BioCentury | Oct 2, 2020
Finance

Sophia aims to parlay expertise of new backers aMoon, Hitachi to grow biopharma business

...angles in that space.”Israeli firm aMoon and Hitachi...
...million, according to BioCentury’s BCIQ database.Camblong said Hitachi...
...into how the genomics data sector is evolving. Hitachi’s...
BioCentury | May 14, 2019
Company News

Management tracks: DBV, Beam, Aeon Biopharma

...was CBO of Serina Therapeutics Inc. (Huntsville, Ala.). Bitar was global head of quality at Hitachi...
BioCentury | Dec 12, 2018
Company News

Management tracks: Merck creates new commercial roles to follow Schechter's exit

...in the U.S. Monteith was COO and site general manager for three manufacturing facilities at Hitachi...
BioCentury | Sep 14, 2017
Company News

Management tracks: SymCel, Taro, Akcea

...Ray Dupuis CFO. He was CFO at Seccuris, an information technology security company acquired by Hitachi...
BioCentury | Aug 4, 2016
Finance

2Q16 Public-Private Partnership Roundup

...and develop small molecules that regulate for circadian rhythm-related disorders. 07/24/2015 Sumitomo Dainippon Pharma Co. Ltd.(Tokyo:4506)Hitachi Ltd....
...University's CiRA is conducting preclinical research on dopaminergic neural progenitor cells produced by Sumitomo and Hitachi...
BioCentury | Apr 4, 2016
Company News

Caladrius Biosciences, Hitachi Chemical deal

...Hitachi Chemical partnered to develop PCT’s cell therapy technology. PCT also granted manufacturing rights to Hitachi...
...other undisclosed Asian countries. PCT will receive $5.6 million in upfront and near-term milestone payments. Hitachi...
...and Hitachi Chemical did not respond to inquiries. Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Hitachi...
BioCentury | Sep 7, 2015
Company News

Sumitomo Dainippon, Hitachi, Kyoto University deal

...Sumitomo, the university’s center for induced pluripotent stem (iPS) cell research and application (CiRA) and Hitachi...
...work with Hitachi to evaluate the validity of processing methods for automatic cell culturing equipment. Hitachi...
...and Kyoto did not respond to inquiries. Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Hitachi Ltd....
BioCentury | Sep 8, 2014
Financial News

Biocartis completes venture financing

...2014-09-04 Type: Venture financing Raised: EUR64.5 million ($84.7 million) Investors: Johnson & Johnson Development Corp.; Hitachi...
BioCentury | Sep 5, 2014
Company News

Biocartis raises EUR 64.5M, spins out newco

...the venture arm of Johnson & Johnson (NYSE:JNJ); and PMV Tina Fund and new investor Hitachi...
BioCentury | Jul 15, 2013
Company News

Base4 Innovation, Hitachi High-Technologies deal

...DNA sequencing company Base4 and medical systems manufacturer Hitachi partnered to develop a long read-length, single-molecule...
...three years. The partners declined to disclose financial terms. Base4 Innovation Ltd. , Cambridge, U.K. Hitachi...
Items per page:
1 - 10 of 68
BioCentury | Oct 2, 2020
Finance

Sophia aims to parlay expertise of new backers aMoon, Hitachi to grow biopharma business

...angles in that space.”Israeli firm aMoon and Hitachi...
...million, according to BioCentury’s BCIQ database.Camblong said Hitachi...
...into how the genomics data sector is evolving. Hitachi’s...
BioCentury | May 14, 2019
Company News

Management tracks: DBV, Beam, Aeon Biopharma

...was CBO of Serina Therapeutics Inc. (Huntsville, Ala.). Bitar was global head of quality at Hitachi...
BioCentury | Dec 12, 2018
Company News

Management tracks: Merck creates new commercial roles to follow Schechter's exit

...in the U.S. Monteith was COO and site general manager for three manufacturing facilities at Hitachi...
BioCentury | Sep 14, 2017
Company News

Management tracks: SymCel, Taro, Akcea

...Ray Dupuis CFO. He was CFO at Seccuris, an information technology security company acquired by Hitachi...
BioCentury | Aug 4, 2016
Finance

2Q16 Public-Private Partnership Roundup

...and develop small molecules that regulate for circadian rhythm-related disorders. 07/24/2015 Sumitomo Dainippon Pharma Co. Ltd.(Tokyo:4506)Hitachi Ltd....
...University's CiRA is conducting preclinical research on dopaminergic neural progenitor cells produced by Sumitomo and Hitachi...
BioCentury | Apr 4, 2016
Company News

Caladrius Biosciences, Hitachi Chemical deal

...Hitachi Chemical partnered to develop PCT’s cell therapy technology. PCT also granted manufacturing rights to Hitachi...
...other undisclosed Asian countries. PCT will receive $5.6 million in upfront and near-term milestone payments. Hitachi...
...and Hitachi Chemical did not respond to inquiries. Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Hitachi...
BioCentury | Sep 7, 2015
Company News

Sumitomo Dainippon, Hitachi, Kyoto University deal

...Sumitomo, the university’s center for induced pluripotent stem (iPS) cell research and application (CiRA) and Hitachi...
...work with Hitachi to evaluate the validity of processing methods for automatic cell culturing equipment. Hitachi...
...and Kyoto did not respond to inquiries. Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Hitachi Ltd....
BioCentury | Sep 8, 2014
Financial News

Biocartis completes venture financing

...2014-09-04 Type: Venture financing Raised: EUR64.5 million ($84.7 million) Investors: Johnson & Johnson Development Corp.; Hitachi...
BioCentury | Sep 5, 2014
Company News

Biocartis raises EUR 64.5M, spins out newco

...the venture arm of Johnson & Johnson (NYSE:JNJ); and PMV Tina Fund and new investor Hitachi...
BioCentury | Jul 15, 2013
Company News

Base4 Innovation, Hitachi High-Technologies deal

...DNA sequencing company Base4 and medical systems manufacturer Hitachi partnered to develop a long read-length, single-molecule...
...three years. The partners declined to disclose financial terms. Base4 Innovation Ltd. , Cambridge, U.K. Hitachi...
Items per page:
1 - 10 of 68